Evan M Hersh

Summary

Affiliation: University of Arizona
Country: USA

Publications

  1. doi request reprint A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma
    Evan M Hersh
    Arizona Cancer Center, University of Arizona, 1515 North Campbell Avenue, Tucson, AZ 85724, USA
    Invest New Drugs 29:489-98. 2011
  2. pmc Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma
    Antoni Ribas
    University of California Los Angeles UCLA, CA, USA
    J Transl Med 8:89. 2010
  3. doi request reprint A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma
    Evan M Hersh
    Department of Medicine, Arizona Cancer Center, Tucson, AZ 85724, USA
    Cancer 116:155-63. 2010
  4. ncbi request reprint Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast
    Julia A Coronella
    Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA
    J Immunol 169:1829-36. 2002
  5. ncbi request reprint Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application
    Katrina T Trevor
    Arizona Cancer Center, 1515 N Campbell Avenue, PO Box 245024, Tucson 85748, USA
    Cancer Immunol Immunother 53:705-14. 2004
  6. ncbi request reprint Clinical applications of dendritic cell vaccination in the treatment of cancer
    Lee D Cranmer
    Department of Hematology and Oncology, The Arizona Cancer Center, University of Arizona University Medical Center, 1515 N Campbell Ave, Tucson, AZ 85724, USA
    Cancer Immunol Immunother 53:275-306. 2004
  7. pmc Ipilimumab pharmacotherapy in patients with metastatic melanoma
    Joanne M Jeter
    Department of Medicine, Arizona Cancer Center, University of Arizona, Tucson, AZ, USA
    Clin Med Insights Oncol 6:275-86. 2012
  8. ncbi request reprint Rodent models of brain metastasis in melanoma
    Lee D Cranmer
    Section of Hematology and Oncology, The Arizona Cancer Center, University of Arizona University Medical Center, Tucson, Arizona 85724, USA
    Melanoma Res 15:325-56. 2005
  9. ncbi request reprint Naturally occurring B-cell responses to breast cancer
    Julia A Coronella-Wood
    Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA
    Cancer Immunol Immunother 52:715-38. 2003

Detail Information

Publications9

  1. doi request reprint A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma
    Evan M Hersh
    Arizona Cancer Center, University of Arizona, 1515 North Campbell Avenue, Tucson, AZ 85724, USA
    Invest New Drugs 29:489-98. 2011
    ..We evaluated the safety and efficacy of ipilimumab alone and in combination with dacarbazine (DTIC) in patients with unresectable, metastatic melanoma...
  2. pmc Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma
    Antoni Ribas
    University of California Los Angeles UCLA, CA, USA
    J Transl Med 8:89. 2010
    ....
  3. doi request reprint A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma
    Evan M Hersh
    Department of Medicine, Arizona Cancer Center, Tucson, AZ 85724, USA
    Cancer 116:155-63. 2010
    ..In the current study, the efficacy and safety of nab-paclitaxel were evaluated in previously treated and chemotherapy-naive patients with metastatic melanoma (MM)...
  4. ncbi request reprint Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast
    Julia A Coronella
    Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA
    J Immunol 169:1829-36. 2002
    ..These data suggest an in situ Ag-driven oligoclonal B cell response to a variety of tumor- and breast-associated Ags...
  5. ncbi request reprint Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application
    Katrina T Trevor
    Arizona Cancer Center, 1515 N Campbell Avenue, PO Box 245024, Tucson 85748, USA
    Cancer Immunol Immunother 53:705-14. 2004
    ..Overall, our results are promising for the large-scale generation of electrofused hybrids comprising DCs and allogeneic tumor cells, that may prove useful in human vaccine trials...
  6. ncbi request reprint Clinical applications of dendritic cell vaccination in the treatment of cancer
    Lee D Cranmer
    Department of Hematology and Oncology, The Arizona Cancer Center, University of Arizona University Medical Center, 1515 N Campbell Ave, Tucson, AZ 85724, USA
    Cancer Immunol Immunother 53:275-306. 2004
    ..Trials published in print through June 2003 are included. We exclude single case reports, except where relevant, and trials with so many variables as to prevent interpretation about DC therapy effects...
  7. pmc Ipilimumab pharmacotherapy in patients with metastatic melanoma
    Joanne M Jeter
    Department of Medicine, Arizona Cancer Center, University of Arizona, Tucson, AZ, USA
    Clin Med Insights Oncol 6:275-86. 2012
    ..We will also discuss the details regarding its use, assessment of response to this drug and other immune-related therapies, and further directions for investigation...
  8. ncbi request reprint Rodent models of brain metastasis in melanoma
    Lee D Cranmer
    Section of Hematology and Oncology, The Arizona Cancer Center, University of Arizona University Medical Center, Tucson, Arizona 85724, USA
    Melanoma Res 15:325-56. 2005
    ....
  9. ncbi request reprint Naturally occurring B-cell responses to breast cancer
    Julia A Coronella-Wood
    Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA
    Cancer Immunol Immunother 52:715-38. 2003
    ....